Effervescent Calcium Magnesium Citrate to Prevent Mineral Metabolism and Renal Complications of Chronic Proton Pump Inhibitor Therapy
Conditions: Osteoporosis; Hypomagnesemia Interventions: Drug: EffCaMgCit; Other: Placebo Sponsor: University of Texas Southwestern Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Calcium | Magnesium | Orthopaedics | Osteoporosis | Proton Pump Inhibitors PPIs | Research